Tylenol

Johnson & Johnson and Kenvue Finalize Separation

Kenvue, the world’s largest pure-play consumer health company by revenue and maker of brands such as Band-Aid, Tylenol, Listerine or Neutrogena, eventually became a fully independent company following the final separation from Johnson & Johnson. A stock swap offer to exchange shares of Johnson & Johnson common stock for shares of Kenvue ended at the end of the day on Aug. 18, 2023.

New J&J CEO Parachuting Into Tough Terrain

Tylenol: J&J Recalls Incorrectly Labeled Products

Musty Odor Sparks Another Tylenol Recall

J&J CEO To Testify On Recalls; Tylenol Brand Dips

J&J Drug Executive Assumes Consumer Unit Oversight

J&J to Unveil Plan to Fix Tylenol Quality Problems

Storm Over J&J's Child Drug Recall Grows